Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

JNJ-38877605

Product Specifications

UNSPSC Description

JNJ-38877605 is an orally active ATP-competitive inhibitor of c-Met with an IC50 of 4 nM, 600-fold selective for c-Met than 200 other tyrosine and serine-threonine kinases[1][2]. JNJ-38877605 inhibits c-Met phosphorylation and regulates lipid accumulation. JNJ-38877605 can be used for tumor and metabolic disease reseach[3][4][5].

Target Antigen

c-Met/HGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer; Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/JNJ-38877605.html

Purity

99.95

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

FC(F)(C1=NN=C2C=CC(C3=CN(C)N=C3)=NN21)C4=CC5=C(N=CC=C5)C=C4

Molecular Weight

377.35

References & Citations

[1]Perera T, et al. JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models. Presented at the 99th AACR Annual Meeting; 2008 Apr 12-16|[2]Wang A, et.al. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway. Cell Commun Signal. 2022 Jan 31;20(1):16.|[3]Park YK, et.al. The Receptor Tyrosine Kinase c-Met Promotes Lipid Accumulation in 3T3-L1 Adipocytes. Int J Mol Sci. 2023 Apr 29;24(9):8086. |[4]De Bacco F, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst. 2011 Apr, 103(8), 645-661.|[5]Torti D, et al. A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. Int J Cancer. 2012, 130(6), 1357-1366.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-50683/JNJ-38877605-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-50683/JNJ-38877605-SDS-MedChemExpress.pdf

Clinical Information

Phase 1

CAS Number

943540-75-8

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Pyruvic acid-13C
HY-Y0781S1-01 1 mg

Pyruvic acid-13C

Ask
View Details
Pyruvic acid-13C
HY-Y0781S1-02 5 mg

Pyruvic acid-13C

Ask
View Details
Pyruvic acid-13C
HY-Y0781S1-03 10 mg

Pyruvic acid-13C

Ask
View Details
Bovine Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) ELISA Kit
CK-bio-23453-01 48 Tests

Bovine Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) ELISA Kit

Ask
View Details
Bovine Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) ELISA Kit
CK-bio-23453-02 96 Tests

Bovine Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) ELISA Kit

Ask
View Details
Linearity FD Tumor Markers for Siemens Atellica/Centaur
K805M-5 10 x 1 mL

Linearity FD Tumor Markers for Siemens Atellica/Centaur

Ask
View Details